Big Changes on Horizon for Regulation of Controlled Substances Continued political and public pressure has pushed sweeping changes to how the industry will transact Controlled Substance business. Agenda for DOJ/DEA Rulemaking 1117-AB47: Suspicious Orders From the...
Pharma Solutions and QPharma Announce Partnership for Comprehensive DEA Compliance Software Solution Pharmaceutical compliance partnership allows manufacturers and distributors to more easily meet and exceed DEA due diligence requirements. Penn Valley, PA — October 5,...
DEA Insights from the 2018 DEA Diversion Conference Background In a letter dated May 23, 2018, AmerisourceBergen threatened to stop supply to Bernie’s Pharmacy because of “an elevated percentage of opioid purchasing…specifically, it was noted that in recent months...